# Ascent Pharmaceuticals Inc – FDA Inspection, Dec 6, 2012

Source: https://www.keypedia.com/records/fda_inspections/ascent-pharmaceuticals-inc/a1e3a760-ebd5-4853-bc1b-2942095b7ebc
Source feed: FDA_Inspections

> FDA inspection 810516 of Ascent Pharmaceuticals Inc, December 06, 2012. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. 9 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 810516
- Company Name: Ascent Pharmaceuticals Inc
- Inspection Date: 2012-12-06
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Documents

- FDA Inspection 1261247 - 2025-02-03
- [FDA Inspection 1229681 - 2024-08-09](https://www.keypedia.com/records/fda_inspections/ascent-pharmaceuticals-inc/ad54fbcb-6020-4316-b662-c5582cc31d0d)
- [FDA Inspection 1179615 - 2022-09-15](https://www.keypedia.com/records/fda_inspections/ascent-pharmaceuticals-inc/23ea7cb5-85bb-4ee6-96ce-1106d4aec03b)
- FDA Inspection 1132410 - 2020-10-13
- [FDA Inspection 1074882 - 2018-11-07](https://www.keypedia.com/records/fda_inspections/ascent-pharmaceuticals-inc/b6df4373-5d5c-4445-88c2-715ab5b7de63)

Company: https://www.keypedia.com/companies/ascent-pharmaceuticals-inc/a6df28ee-9e4e-4fae-8eed-dbe5eb870593

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c